Compounds > ciprofloxacin

ciprofloxacin and ginsenosides

ciprofloxacin has been researched along with ginsenosides in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, Q; He, J; Liu, J; Lu, M; Sun, X; Sun, Y; Wang, G; Wang, Y; Zhang, J; Zhang, X; Zhou, F1
Esfahani, G; Salimi, A; Sharif Makhmal Zadeh, B1
Long, J; Lu, C; Pan, X; Sun, M; Wu, C; Zhu, C1

Other Studies

3 other study(ies) available for ciprofloxacin and ginsenosides

ArticleYear
Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    European journal of pharmacology, 2014, Oct-05, Volume: 740

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Ginsenosides; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Peritonitis; Protein Conformation; Pyronine; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus

2014
Permeability of Ciprofloxacin-Loaded Polymeric Micelles Including Ginsenoside as P-glycoprotein Inhibitor through a Caco-2 Cells Monolayer as an Intestinal Absorption Model.
    Molecules (Basel, Switzerland), 2018, Jul-31, Volume: 23, Issue:8

    Topics: Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Ciprofloxacin; Diffusion; Drug Carriers; Drug Compounding; Drug Liberation; Gene Expression; Ginsenosides; Humans; Intestinal Absorption; Kinetics; Micelles; Models, Biological; Particle Size

2018
PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Ginsenosides; HaCaT Cells; Humans; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Microspheres; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcal Skin Infections; Staphylococcus aureus

2020